|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Scrubs & Beyond Announces 2015 Model Search
Scrubs & Beyond is on the hunt for a #ScrubsModel! You could win the chance to be a part of their Summer 2016 photo shoot! For more information and to enter, click here. In addition to the photo shoot, the winner will also receive round-trip airfare to St. Louis, a two night stay in an area hotel and a $300 Scrubs & Beyond gift card. Second and third place will receive a $200 and a $100 gift card, respectively.
| Share this article:
Submit an abstract for the 25th Annual ITNS Symposium
You have the knowledge and expertise, so submit an abstract! Network with other transplant nursing professionals and make valuable connections. Submit an abstract before the October 12, 2015 deadline. Questions about abstract submission? Contact Jennifer Wahl, ITNS Education Manager, at firstname.lastname@example.org.
Product Feature: Introduction to Transplant Nursing Core Competencies
In user-friendly, bulleted format, the Introduction to Transplant Nursing: Core Competencies describes the competencies relative to the fifteen domains of transplant nursing practice. As Sandra Cupples, PhD RN, noted in her review of this product "Transplant nurses have an obligation to achieve and maintain competency in practice. Managers have an obligation to assure the ongoing competencies of transplant nursing staff. This book is an indispensable resource for both." Utilize your member discount and purchase your copy today!
Spain breaks its own record to stay global leader in organ transplants
While Spain accounts for only 0.7 percent of the global population, it conducted around four percent of all transplants carried out worldwide in 2014, breaking its own record when it comes to organ donation, new figures from the Spain's National Transplant Organization (ONT) reveal.
Spain's organ donation figures are currently 36 donations per every one million people which is "much higher" than the EU average (19.6) and the U.S. average (26.6) according to a statement released by Spain’s Health Ministry.
Transplant surgeons revive hearts after death
Transplant surgeons have started using a device that allows them to "reanimate" hearts from people who have recently died, and use the organs to save others.
The "heart in a box" is a wheeled cart with an oxygen supply, a sterile chamber, and tubing to clamp onto a donor heart and keep it fed with blood and nutrients. Doctors say it may extend the time a heart can last outside the body and is letting them recover hearts from donors who haven't been eligible before.
New cholesterol drugs will lead to huge healthcare cost increases but few benefits
Fierce Health Finance
The U.S. healthcare system has had a hard time digesting the recent debut of Sovaldi and Harvoni, two drugs that have proven effective in curing hepatitis C but cost close to $100,000 for a regimen. But despite their stupefying cost, in the long run such drugs could actually save money along with lives. The only effective cure for hepatitis C prior to the introduction of those medications was a liver transplant, one of the most complicated and expensive surgeries to perform — it's a procedure that starts at about $500,000 and moves on from there, according to Sutter Health.
Like ITNS on Facebook! Visit the ITNS Facebook page for the latest ITNS and transplant news.
Paul's Law would remove disability as factor in transplant decisions
By Lynn Hetzler
The State of Pennsylvania is considering a proposal that removes disabilities as factors in decisions regarding organ transplant. Democratic state Sen. John Sabatina proposed the idea after hearing the story of a Schuylkill County man, Paul Corby, who was denied a spot on a transplant list partially due to his autism.
Role of heart-assist devices shifts as technology, management improve
Six years ago, Brenda Mays was in and out of the hospital with heart failure so often that all the nurses knew her by name.
"I would go to the hospital on a Monday and get out on a Friday, and Sunday night, I was back in the hospital," she recalls. "I was just so weak."
Mays was ineligible for a heart transplant, so doctors suggested she get a left ventricular assist device — an implantable heart pump that would assist, rather than replace, her failing heart. She resisted until another patient told her how the device had changed his life.
Miss an issue of the ITNS Insider? Click here to visit the the ITNS Insider archive page.
Largest study to date shows no benefit to gene transfer therapy in heart failure
Gene transfer therapy aimed at correcting an enzyme abnormality involved in myocardial contraction and relaxation did not improve outcomes in heart failure patients with reduced ejection fraction, results of the CUPID 2 study show.
The findings, presented at ESC Congress 2015, represent the largest gene transfer study to date in this population.
Demand for organ donation now higher than ever before
A TOP transplant surgeon has backed the Oxford Mail organ donation campaign saying more donors are needed than ever before.
Doctors around the world can now save organs that would otherwise be wasted thanks to the "world-leading" work of Oxford University Hospitals NHS Trust's Dr Rutger Ploeg and his team.
But he warned such technological advancements meant more people than ever before are now waiting for life-saving organs.
Transplant Registry completes 50th swap kidney transplant
The country's first and only swap transplant registry last week completed the 50th swap kidney transplant. This means, with the help of this registry, 50 pairs, ie 100 people, have exchanged kidneys in the last five years.
Among the beneficiaries of the Apex Swap Transplant Registry (ASTR), a kind of matchmaking service for kidney failure patients and organ donors, are Parag Doshi and Awdesh Gupta.
A racial gap in kidney transplants closes but work remains
A racial gap in kidney transplants appears to have closed, a 13-year study found.
Rates of such transplants among white patients used to far surpass those in blacks, but U.S. data on nearly 200,000 end-stage kidney disease patients shows that disparity had disappeared by 2010. Rates remained stable in 2011 and that trend likely has continued, said Dr. Jesse Sammon, the senior author and a urologist-researcher at the Henry Ford Health System in Detroit.
UDCA reduces risk for recurrent cirrhosis after liver transplantation
Liver transplant recipients treated with ursodeoxycholic acid had a lower risk for recurrent primary biliary cirrhosis, according to published findings in the Journal of Hepatology. Researchers collected and analyzed data of 90 patients enrolled across five French and Swiss transplant centers between 1988 and 2010 who underwent liver transplant for primary biliary cirrhosis (PBC). Nineteen patients underwent preventive therapy with 10 mg/kg to 15 mg/kg ursodeoxycholic acid (UDCA) daily.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063